Viewing Study NCT01844869


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-27 @ 10:38 AM
Study NCT ID: NCT01844869
Status: COMPLETED
Last Update Posted: 2015-01-30
First Post: 2013-04-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module